SpringWorks Therapeutics, Inc. (SWTX)
NASDAQ: SWTX · Real-Time Price · USD
46.12
-0.14 (-0.30%)
At close: May 12, 2025, 4:00 PM
46.10
-0.02 (-0.04%)
After-hours: May 12, 2025, 7:56 PM EDT
SpringWorks Therapeutics Employees
SpringWorks Therapeutics had 368 employees as of December 31, 2024. The number of employees increased by 63 or 20.66% compared to the previous year.
Employees
368
Change (1Y)
63
Growth (1Y)
20.66%
Revenue / Employee
$596,929
Profits / Employee
-$690,035
Market Cap
3.47B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SWTX News
- 12 days ago - SPRINGWORKS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of SpringWorks Therapeutics, Inc. - SWTX - Business Wire
- 14 days ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of SpringWorks Therapeutics, Inc. - PRNewsWire
- 14 days ago - Germany's Merck Agrees to Buy US Biotech SpringWorks Therapeutics for Almost $4B - Investopedia
- 14 days ago - Germany's Merck Set to Buy SpringWorks in $3.9 Billion Deal - WSJ
- 14 days ago - Germany's Merck KGaA in $3.9 bln deal to acquire US biotech firm SpringWorks - Reuters
- 14 days ago - Merck KGaA, Darmstadt, Germany to Acquire SpringWorks Therapeutics to Accelerate Sustainable Growth of Healthcare Business - GlobeNewsWire
- 14 days ago - Merck KGaA, Darmstadt, Germany, to Acquire US Biopharma Company SpringWorks Therapeutics to Accelerate Sustainable Growth of Healthcare Business - Business Wire
- 15 days ago - SpringWorks Therapeutics Announces Expected CHMP Opinion in Q2 2025 for Nirogacestat for the Treatment of Adults with Desmoid Tumors in the European Union - GlobeNewsWire